Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung

Francis J Martin1, Dane Parker, Bryan S Harfenist

  • 1Department of Pharmacology, Columbia University, New York, NY 10032, USA.

Infection and Immunity
|March 16, 2011
PubMed

Insights

CD11c(+) cells and CD4(+) cell recruitment are crucial in severe Staphylococcus aureus lung infections. Their role in inflammation and host response significantly impacts mortality and disease severity.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Microbiology

Background:

  • Staphylococcus aureus, particularly MRSA, causes severe lung infections with high mortality.
  • The host's inflammatory response, especially early on, significantly contributes to lung damage.

Purpose of the Study:

  • To investigate the role of CD11c(+) leukocytes in the host response to methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infection.
  • To understand the contribution of dendritic cells (DCs) and their associated pathways in MRSA-induced lung pathology.

Main Methods:

  • Utilized clodronate to deplete alveolar macrophages and diphtheria toxin to deplete CD11c(+) dendritic cells in mouse models.
  • Administered anti-CXCR3 antibody to assess the role of the CXCR3 pathway in MRSA infection.
  • Measured bacterial load, cell populations (DCs, CD4+ cells, PMNs), inflammatory mediators (IL-17A/F, CXCL10, IFN-γ, TNF), and mortality.

Main Results:

  • Alveolar macrophage depletion increased DCs, CD4+ cells, mortality, and specific inflammatory mediators (IL-17A/F, CXCL10) but did not affect bacterial load or PMNs.
  • Dendritic cell depletion increased bacterial load but not mortality.
  • Both DCs and airway epithelial cells produced CXCL9, -10, and -11 in response to S. aureus.
  • Anti-CXCR3 antibody treatment reduced CD4+ cells and pulmonary inflammation.

Conclusions:

  • CD11c(+) cells, CXCR3 ligand induction, and CD4(+) cell recruitment play a significant role in the pathogenesis of severe MRSA pulmonary infections.
  • The interplay between innate and adaptive immune cells, particularly DCs and CD4+ T cells, is critical in MRSA lung infection outcomes.
  • Targeting the CXCR3 pathway may offer therapeutic strategies for managing severe S. aureus pneumonia.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...